TABLE 1 North America Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 2 North America Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Congestive Heart Failure (CHF) Treatment Devices Market
TABLE 4 Product Launches And Product Expansions– Congestive Heart Failure (CHF) Treatment Devices Market
TABLE 5 Acquisition and Mergers– Congestive Heart Failure (CHF) Treatment Devices Market
TABLE 6 Approvals and Trials - Congestive Heart Failure (CHF) Treatment Devices Market
TABLE 7 North America Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 8 North America Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 9 North America Pacemakers Market by Country, 2018 - 2021, USD Million
TABLE 10 North America Pacemakers Market by Country, 2022 - 2028, USD Million
TABLE 11 North America Implantable Cardioverter Defibrillators Market by Country, 2018 - 2021, USD Million
TABLE 12 North America Implantable Cardioverter Defibrillators Market by Country, 2022 - 2028, USD Million
TABLE 13 North America Cardiac Resynchronization Therapy Market by Country, 2018 - 2021, USD Million
TABLE 14 North America Cardiac Resynchronization Therapy Market by Country, 2022 - 2028, USD Million
TABLE 15 North America Ventricular Assist Devices Market by Country, 2018 - 2021, USD Million
TABLE 16 North America Ventricular Assist Devices Market by Country, 2022 - 2028, USD Million
TABLE 17 North America Congestive Heart Failure (CHF) Treatment Devices Market by Country, 2018 - 2021, USD Million
TABLE 18 North America Congestive Heart Failure (CHF) Treatment Devices Market by Country, 2022 - 2028, USD Million
TABLE 19 US Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 20 US Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 21 US Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 22 US Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 23 Canada Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 24 Canada Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 25 Canada Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 26 Canada Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 27 Mexico Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 28 Mexico Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 29 Mexico Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 30 Mexico Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 31 Rest of North America Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 32 Rest of North America Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 33 Rest of North America Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 34 Rest of North America Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 35 key Information – Boston Scientific Corporation
TABLE 36 key Information – MicroPort Scientific Corporation
TABLE 37 Key Information – Abbott Laboratories
TABLE 38 Key Information – Medtronic PLC
TABLE 39 Key Information – ABIOMED, Inc.
TABLE 40 Key Information – Berlin Heart GmbH
TABLE 41 Key Information – JARVIK HEART, INC.
TABLE 42 Key Information – Lepu Medical Technology (Beijing) Co., Ltd.
TABLE 43 Key Information – BIOTRONIK SE & Co. KG
TABLE 44 Key Information – Osypka Medical GmbH
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Acquisitions and Mergers: 2018, Jul – 2022, Feb) Leading Players
FIG 5 Recent strategies and developments: Boston Scientific Corporation
FIG 6 Recent Strategies and Developments: MicroPort Scientific Corporation
FIG 7 Recent strategies and developments: Abbott Laboratories
FIG 8 Recent strategies and developments: Abiomed, Inc.
Unique Offerings 